Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11958993rdf:typepubmed:Citationlld:pubmed
pubmed-article:11958993lifeskim:mentionsumls-concept:C0006684lld:lifeskim
pubmed-article:11958993lifeskim:mentionsumls-concept:C0752246lld:lifeskim
pubmed-article:11958993lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:11958993lifeskim:mentionsumls-concept:C2698650lld:lifeskim
pubmed-article:11958993lifeskim:mentionsumls-concept:C1707271lld:lifeskim
pubmed-article:11958993pubmed:issue6lld:pubmed
pubmed-article:11958993pubmed:dateCreated2002-4-17lld:pubmed
pubmed-article:11958993pubmed:abstractTextSynthesis and structure-activity relationship (SAR) studies of L-cysteine-based N-type calcium channel blockers are described. In the course of exploring SAR of the N- and C-terminal substituents, the L-cysteine derivative was found to be a potent N-type calcium channel blocker with an IC(50) value of 0.14 microM on IMR-32 assay. Compound showed 12-fold selectivity for N-type over L-type calcium channels on AtT-20 assay.lld:pubmed
pubmed-article:11958993pubmed:languageenglld:pubmed
pubmed-article:11958993pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11958993pubmed:citationSubsetIMlld:pubmed
pubmed-article:11958993pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11958993pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11958993pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11958993pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11958993pubmed:statusMEDLINElld:pubmed
pubmed-article:11958993pubmed:monthMarlld:pubmed
pubmed-article:11958993pubmed:issn0960-894Xlld:pubmed
pubmed-article:11958993pubmed:authorpubmed-author:MaegawaHitosh...lld:pubmed
pubmed-article:11958993pubmed:authorpubmed-author:KatsubeNobuoNlld:pubmed
pubmed-article:11958993pubmed:authorpubmed-author:TodaMasaakiMlld:pubmed
pubmed-article:11958993pubmed:authorpubmed-author:KatoMasashiMlld:pubmed
pubmed-article:11958993pubmed:authorpubmed-author:SekoTakuyaTlld:pubmed
pubmed-article:11958993pubmed:authorpubmed-author:KohnoHiroshiHlld:pubmed
pubmed-article:11958993pubmed:authorpubmed-author:OnoShizukaSlld:pubmed
pubmed-article:11958993pubmed:authorpubmed-author:HashimuraKazu...lld:pubmed
pubmed-article:11958993pubmed:authorpubmed-author:TakimizuHidey...lld:pubmed
pubmed-article:11958993pubmed:authorpubmed-author:NakaiKatsuhik...lld:pubmed
pubmed-article:11958993pubmed:issnTypePrintlld:pubmed
pubmed-article:11958993pubmed:day25lld:pubmed
pubmed-article:11958993pubmed:volume12lld:pubmed
pubmed-article:11958993pubmed:ownerNLMlld:pubmed
pubmed-article:11958993pubmed:authorsCompleteYlld:pubmed
pubmed-article:11958993pubmed:pagination915-8lld:pubmed
pubmed-article:11958993pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:11958993pubmed:meshHeadingpubmed-meshheading:11958993...lld:pubmed
pubmed-article:11958993pubmed:meshHeadingpubmed-meshheading:11958993...lld:pubmed
pubmed-article:11958993pubmed:meshHeadingpubmed-meshheading:11958993...lld:pubmed
pubmed-article:11958993pubmed:meshHeadingpubmed-meshheading:11958993...lld:pubmed
pubmed-article:11958993pubmed:meshHeadingpubmed-meshheading:11958993...lld:pubmed
pubmed-article:11958993pubmed:meshHeadingpubmed-meshheading:11958993...lld:pubmed
pubmed-article:11958993pubmed:meshHeadingpubmed-meshheading:11958993...lld:pubmed
pubmed-article:11958993pubmed:meshHeadingpubmed-meshheading:11958993...lld:pubmed
pubmed-article:11958993pubmed:year2002lld:pubmed
pubmed-article:11958993pubmed:articleTitleStructure-activity study of L-cysteine-based N-type calcium channel blockers: optimization of N- and C-terminal substituents.lld:pubmed
pubmed-article:11958993pubmed:affiliationMinase Research Institute, Ono Pharmaceutical Co., Ltd., 3-1-1 Sakurai, Shimamoto, Mishima, 618-8585, Osaka, Japan. seko@ono.co.jplld:pubmed
pubmed-article:11958993pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:11958993lld:chembl